<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for CNDO</title>
    <link />
    <description>Headlines for Coronado Biosciences, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Coronado Biosciences' CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1415121-coronado-biosciences-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 08 May 2013 14:57:06 GMT</pubDate>
    </item>
    <item>
      <title>Billionaire Paul Singer's Most Dramatically Built Positions</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1382201-billionaire-paul-singer-s-most-dramatically-built-positions.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 29 Apr 2013 16:08:00 GMT</pubDate>
    </item>
    <item>
      <title>2 Biotech Stocks Soaring on Big Volume</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/2-biotech-stocks-soaring-big-volume.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Mon, 22 Apr 2013 14:34:00 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Hitting 52-Week Highs</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3516203/stocks-hitting-52-week-highs.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 22 Apr 2013 10:34:56 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Bank of America Initiates Coronado Biosciences with Buy on New Autoimmune Approach</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/04/3515371/update-bank-of-america-initiates-coronado-biosciences-wi.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 22 Apr 2013 08:38:32 GMT</pubDate>
    </item>
    <item>
      <title>Why Coronado Biosciences Is Poised to Plunge</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/15/why-coronado-biosciences-is-poised-to-plunge/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 15 Apr 2013 11:49:00 GMT</pubDate>
    </item>
    <item>
      <title>Coronado Biosciences to Sell Common Stock in ATM Offering</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3489332/coronado-biosciences-to-sell-common-stock-in-atm-offering.aspx</link>
      <author>Benzinga</author>
      <pubDate>Thu, 11 Apr 2013 08:35:07 GMT</pubDate>
    </item>
    <item>
      <title>Coronado Biosciences CEO Hosts Analyst Day (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1331261-coronado-biosciences-ceo-hosts-analyst-day-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 09 Apr 2013 20:49:04 GMT</pubDate>
    </item>
    <item>
      <title>Coronado Biosciences' CEO Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1273641-coronado-biosciences-ceo-discusses-q4-2012-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 14 Mar 2013 11:15:05 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Piper Jaffray Initiates Coronado Biosciences at Overweight on Compelling Clinical Results</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3380959/update-piper-jaffray-initiates-coronado-biosciences-at-o.aspx</link>
      <author>Benzinga</author>
      <pubDate>Fri, 01 Mar 2013 09:01:14 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's Top Initiations</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/initiation/13/03/3380838/benzingas-top-initiations.aspx</link>
      <author>Benzinga</author>
      <pubDate>Fri, 01 Mar 2013 07:31:43 GMT</pubDate>
    </item>
    <item>
      <title>Weekly CEO Buys Highlight: CNDO</title>
      <link>http://www.fool.com/news/xt/gurufocus/www.gurufocus.com/news/205600/weekly-ceo-buys-highlight-cndo.aspx</link>
      <author>GuruFocus</author>
      <pubDate>Mon, 21 Jan 2013 13:12:18 GMT</pubDate>
    </item>
    <item>
      <title>Weekly CEO Buys Highlight: CNDO</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/weekly-ceo-buys-highlight-cndo-cm209179.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Mon, 21 Jan 2013 12:14:01 GMT</pubDate>
    </item>
    <item>
      <title>Coronado Biosciences New CEO Makes First Buy of the Year, Worth $114K</title>
      <link>http://www.fool.com/news/xt/gurufocus/www.gurufocus.com/news/205165/coronado-biosciences-new-ceo-makes-first-buy-of-the-year-worth-114k.aspx</link>
      <author>GuruFocus</author>
      <pubDate>Wed, 16 Jan 2013 18:09:07 GMT</pubDate>
    </item>
    <item>
      <title>Coronado Biosciences New CEO Makes First Buy of the Year, Worth $114K</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/coronado-biosciences-new-ceo-makes-first-buy-of-the-year-worth-114k-cm208270.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Wed, 16 Jan 2013 17:14:17 GMT</pubDate>
    </item>
    <item>
      <title>12 Stocks Expected to Rise by 50% to 100% (or More) in 2013 (AMRN, CRZO, CNDO, EMKR, ETRM, EXAS, GAL</title>
      <link>http://www.fool.com/news/xt/247wallst/247wallst.com/2013/01/04/12-stocks-expected-to-rise-by-50-to-100-or-more-in-2013-amrn-crzo-cndo-emkr-etrm-exas-gale-mx-oedv-regi-spwr-sgyp/.aspx</link>
      <author>247wallst</author>
      <pubDate>Fri, 04 Jan 2013 05:42:49 GMT</pubDate>
    </item>
    <item>
      <title>Coronado Amends Ovamed Agreement - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/89674/coronado-amends-ovamed-agreement.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 03 Jan 2013 18:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Coronado Biosciences Announces Acquisition of TSO Manufacturing Rights from Ovamed</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/12/12/3200990/coronado-biosciences-announces-acquisition-of-tso-manufacturing-rights-from-ovame.aspx</link>
      <author>Benzinga</author>
      <pubDate>Thu, 27 Dec 2012 07:36:21 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Wedbush Securities Initiates Coronado Biosciences at Outperform on Outlook for CNDO-201</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/12/12/3191240/update-wedbush-securities-initiates-coronado-biosciences.aspx</link>
      <author>Benzinga</author>
      <pubDate>Thu, 20 Dec 2012 13:06:32 GMT</pubDate>
    </item>
    <item>
      <title>What No One Is Saying About Paramount Biosciences: 3 Case Histories And 4 Companies To Avoid</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1071151-what-no-one-is-saying-about-paramount-biosciences-3-case-histories-and-4-companies-to-avoid.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 18 Dec 2012 13:27:49 GMT</pubDate>
    </item>
  </channel>
</rss>
